Jin-Kai Feng

W. Lau, Kang Wang, Shuqun Cheng, 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Association of Preoperative Coagulability With Incidence and Extent of Portal Vein Tumor Thrombus and Survival Outcomes in Hepatocellular Carcinoma After Hepatectomy: A Large-Scale, Multicenter Study

W. Lau, Kang Wang, Z. Zhen, 2021, Frontiers in Oncology.

Efficacy and safety of TACE combined with lenvatinib and PD‐1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study

Wei-Wei Pan, Kang Wang, Jie Shi, 2023, Cancer medicine.

Comparison of different surgical interventions for hepatocellular carcinoma with bile duct tumor thrombus: a systematic review and meta-analysis

Kang Wang, Shuqun Cheng, Jie Shi, 2020, Annals of translational medicine.

A reasonable identification of the early recurrence time based on microvascular invasion for hepatocellular carcinoma after R0 resection: A multicenter retrospective study

Jie Shi, Xiuping Zhang, Zongtao Chai, 2023, Cancer medicine.

CHML promotes liver cancer metastasis by facilitating Rab14 recycle

Lin Qiu, D. Xie, Xiao-Fan Wang, 2019, Nature Communications.

Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors

Kang Wang, Jie Shi, Wei-xing Guo, 2023, BMC Cancer.

Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation

Kang Wang, Yuqiang Cheng, Jin-Kai Feng, 2023, BMC Cancer.

Postoperative adjuvant aspirin for patients with hepatitis B virus-related hepatocellular carcinoma and portal vein tumor thrombus: An open-label, randomized controlled trial

Yabo Jiang, Wei-xing Guo, Jin-Kai Feng, 2023, Heliyon.

Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: multicenter propensity score-matched study

W. Lau, Jie Shi, Jie Xue, 2023, Hepatology International.

Efficacy and Safety of Transarterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma Associated with Bile Duct Tumor Thrombus: A Real-World Retrospective Cohort Study

Shuqun Cheng, Jie Shi, Ju-xian Sun, 2021, Cancer management and research.

Preoperative and Prognostic Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Review Based on Artificial Intelligence

Kang Wang, Jin-Kai Feng, Zong-Han Liu, 2023, Technology in cancer research & treatment.

Prognostic and Immunotherapeutic Predictive Value of CAD Gene in Hepatocellular Carcinoma: Integrated Bioinformatics and Experimental Analysis.

Jie Shi, Ju-xian Sun, Jin-Kai Feng, 2024, Molecular biotechnology.

Salvage Surgery for Initially Unresectable HCC With PVTT Converted by Locoregional Treatment Plus Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody

Kang Wang, Jie Shi, Wei-xing Guo, 2024, The oncologist.

Disulfidptosis-Associated lncRNAs are Potential Biomarkers for Predicting Immune Response and Prognosis Within Individuals Diagnosed with Hepatocellular Carcinoma

Jin-Kai Feng, Shu-Qun Cheng, Xu Wang, 2023, Hepatic medicine : evidence and research.